Bridger Management
Latest statistics and disclosures from Bridger Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are LLY, UBER, VRTX, MS, TEVA, and represent 50.28% of Bridger Management's stock portfolio.
- Added to shares of these 4 stocks: BLCO (+$7.4M), OSCR, MLCO, HLVX.
- Started 2 new stock positions in BLCO, OSCR.
- Reduced shares in these 9 stocks: EDR (-$11M), , TEVA (-$8.4M), CYTK, ALNY, LLY, , BBWI, SPOT.
- Sold out of its positions in ATRC, CYTK, EDR, THC, SPOT.
- Bridger Management was a net seller of stock by $-36M.
- Bridger Management has $194M in assets under management (AUM), dropping by -12.39%.
- Central Index Key (CIK): 0001166309
Tip: Access up to 7 years of quarterly data
Positions held by Bridger Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Bridger Management
Bridger Management holds 28 positions in its portfolio as reported in the June 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Eli Lilly & Co. (LLY) | 11.5 | $22M | -11% | 25k | 905.38 |
|
Uber Technologies (UBER) | 11.3 | $22M | 302k | 72.68 |
|
|
Vertex Pharmaceuticals Incorporated (VRTX) | 9.9 | $19M | 41k | 468.72 |
|
|
Morgan Stanley Com New (MS) | 9.4 | $18M | 188k | 97.19 |
|
|
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 8.2 | $16M | -34% | 981k | 16.25 |
|
Pfizer (PFE) | 5.0 | $9.8M | 351k | 27.98 |
|
|
Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 4.6 | $9.0M | 52k | 173.81 |
|
|
Alnylam Pharmaceuticals (ALNY) | 4.6 | $9.0M | -30% | 37k | 243.00 |
|
Bath & Body Works In (BBWI) | 4.5 | $8.7M | -14% | 222k | 39.05 |
|
Bausch Plus Lomb Corp Common Shares (BLCO) | 3.8 | $7.4M | NEW | 506k | 14.52 |
|
Melco Resorts And Entmnt Adr (MLCO) | 3.8 | $7.3M | +13% | 984k | 7.46 |
|
Caesars Entertainment (CZR) | 3.0 | $5.9M | 148k | 39.74 |
|
|
Xenon Pharmaceuticals (XENE) | 2.9 | $5.7M | 147k | 38.99 |
|
|
Geron Corporation (GERN) | 2.9 | $5.7M | 1.3M | 4.24 |
|
|
Springworks Therapeutics (SWTX) | 2.8 | $5.4M | 145k | 37.67 |
|
|
Dex (DXCM) | 1.7 | $3.3M | 29k | 113.38 |
|
|
Catalyst Pharmaceutical Partners (CPRX) | 1.5 | $2.9M | 185k | 15.49 |
|
|
Alphabet Cap Stk Cl A (GOOGL) | 1.3 | $2.5M | 14k | 182.15 |
|
|
Quanterix Ord (QTRX) | 1.1 | $2.0M | 155k | 13.21 |
|
|
Hillevax (HLVX) | 1.0 | $2.0M | +29% | 140k | 14.46 |
|
Microsoft Corporation (MSFT) | 1.0 | $1.9M | 4.2k | 446.95 |
|
|
Terns Pharmaceuticals (TERN) | 0.9 | $1.7M | 247k | 6.81 |
|
|
Uniqure Nv SHS (QURE) | 0.8 | $1.6M | 362k | 4.48 |
|
|
Oscar Health Cl A (OSCR) | 0.8 | $1.5M | NEW | 96k | 15.82 |
|
Amazon (AMZN) | 0.7 | $1.4M | 7.3k | 193.25 |
|
|
Toast Cl A (TOST) | 0.7 | $1.4M | 53k | 25.77 |
|
|
Nextdecade Corp (NEXT) | 0.3 | $539k | 68k | 7.94 |
|
|
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $7.7k | 467k | 0.02 |
|
Past Filings by Bridger Management
SEC 13F filings are viewable for Bridger Management going back to 2010
- Bridger Management 2024 Q2 filed Aug. 14, 2024
- Bridger Management 2024 Q1 filed May 15, 2024
- Bridger Management 2023 Q2 amended filed March 25, 2024
- Bridger Management 2023 Q3 amended filed March 25, 2024
- Bridger Management 2023 Q4 amended filed March 25, 2024
- Bridger Management 2021 Q4 amended filed March 25, 2024
- Bridger Management 2022 Q3 amended filed March 25, 2024
- Bridger Management 2022 Q4 amended filed March 25, 2024
- Bridger Management 2023 Q1 amended filed March 25, 2024
- Bridger Management 2023 Q4 filed Feb. 14, 2024
- Bridger Management 2023 Q3 filed Nov. 14, 2023
- Bridger Management 2023 Q2 filed Aug. 14, 2023
- Bridger Management 2023 Q1 filed May 15, 2023
- Bridger Management 2022 Q4 filed Feb. 15, 2023
- Bridger Management 2022 Q3 filed Nov. 14, 2022
- Bridger Management 2022 Q2 filed Aug. 15, 2022